iRhythm Holdings, Inc.

IRTC ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $747.1M $591.8M $492.7M $410.9M $322.8M $265.2M $214.6M $147.3M
Cost of Revenue $219.9M $184.3M $160.9M $129.3M $109.3M $70.3M $52.5M $38.8M
Gross Profit $527.3M $407.5M $331.8M $281.6M $213.6M $194.9M $162.1M $108.5M
Gross Margin 70.6% 68.9% 67.3% 68.5% 66.2% 73.5% 75.5% 73.7%
Operating Expenses
Research & Development $60.2M $46.6M $38.7M $41.3M $37.3M $20.9M
SG&A Expense $492.6M $418.6M $385.6M $322.2M $274.8M $197.2M $179.5M $133.3M
Operating Income $-57.4M $-115.5M $-125.2M $-113.8M $-99.9M $-43.7M $-54.8M $-45.7M
Operating Margin -7.7% -19.5% -25.4% -27.7% -31.0% -16.5% -25.5% -31.0%
Interest Expense $3.7M $4.1M $1.2M $1.5M $1.6M $3.1M
Pretax Income $-43.6M $-112.7M $-122.7M $-115.9M $-101.0M $-43.6M $-54.5M $-50.3M
Income Tax Expense $953.0K $565.0K $750.0K $269.0K $367.0K $229.0K $65.0K $44.0K
Net Income $-44.6M $-113.3M $-123.4M $-116.2M $-101.4M $-43.8M $-54.6M $-50.4M
Net Margin -6.0% -19.1% -25.0% -28.3% -31.4% -16.5% -25.4% -34.2%
EPS (Basic) $-1.39 $-3.63 $-4.04 $-3.88 $-3.46 $-1.58 $-2.16 $-2.11
EPS (Diluted) $-1.39 $-3.63 $-4.04 $-3.88 $-3.46 $-1.58 $-2.16 $-2.11
Shares Outstanding (Basic) 32.0M 31.2M 30.5M 29.9M 29.3M 27.8M 25.3M 24.4M
Shares Outstanding (Diluted) 32.0M 31.2M 30.5M 29.9M 29.3M 27.8M 25.3M 24.4M
Dividends Per Share
← Newer Page 1 of 2 Older →